WHAM-A Prospective Study of Weight and Body Composition After Risk-Reducing Bilateral Salpingo-oophorectomy

被引:0
|
作者
Price, Sarah A. L. [1 ,2 ,3 ,4 ,10 ]
Finch, Sue [5 ]
Krejany, Efrosinia [6 ]
Jiang, Hongyuan [7 ]
Kale, Ashwini [1 ,8 ]
Domchek, Susan [9 ]
Wrede, David [2 ,3 ]
Wark, John D. [1 ,8 ]
Hickey, Martha [2 ,6 ]
机构
[1] Univ Melbourne, Dept Med, Grattan St, Parkville, Vic 3050, Australia
[2] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic 3051, Australia
[3] Royal Womens Hosp, Dept Obstet Med, Melbourne, Vic 3051, Australia
[4] Royal Melbourne Hosp, Dept Diabet & Endocrinol, Grattan St, Parkville, Vic 3010, Australia
[5] Univ Melbourne, Stat Consulting Ctr, Sch Math & Stat, Carlton, Vic 3053, Australia
[6] Royal Womens Hosp, Dept Obstet & Gynaecol, Melbourne, Vic 3051, Australia
[7] Qingdao Univ, Affiliated Hosp, Dept Sports Med, Qingdao 266000, Shandong, Peoples R China
[8] Royal Melbourne Hosp, Dept Diabet & Endocrinol, Bone & Mineral Med, Parkville, Vic 3010, Australia
[9] Univ Penn, Basser Ctr BRCA, Dept Oncol, Philadelphia, PA 19104 USA
[10] Univ Melbourne, Dept Med, 300 Grattan St, Parkville, Vic 3050, Australia
基金
英国医学研究理事会;
关键词
risk reducing salpingo-oophorectomy; surgical menopause; body composition; body fat; hormone replacement therapy; VISCERAL ADIPOSE-TISSUE; HORMONE-THERAPY; MENOPAUSE WHAM; WOMEN; ASSOCIATION; SYMPTOMS; HAPPENS; OVARIAN; HEALTH; BREAST;
D O I
10.1210/clinem/dgad385
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Body weight and composition may change over the natural menopause transition. Whether surgical menopause has similar effects, and the impact of hormone replacement therapy (HRT), are unknown. Understanding the metabolic effects of surgical menopause will inform clinical care. Objective To prospectively measure weight and body composition over 24 months following surgical menopause compared with a similar comparison group who retained their ovaries. Methods Prospective observational study of weight change from baseline to 24 months in 95 premenopausal women at elevated risk of ovarian cancer planning risk-reducing salpingo-oophorectomy (RRSO) and 99 comparators who retained their ovaries. Change in body composition from baseline to 24 months was also assessed by dual-energy x-ray absorptiometry in a subgroup of 54 women who underwent RRSO and 81 comparators who retained their ovaries. In the subgroup, weight, fat mass, lean mass, and abdominal fat measures were compared between groups. Results At 24 months both groups had gained weight (RRSO 2760 & PLUSMN; 4860 g vs comparators 1620 & PLUSMN; 4540 g) with no difference between groups (mean difference 730 g; 95% CI 920 g to 2380 g; P = .383). In the body composition subgroup, there was no difference in weight between groups at 24 months (mean difference 944 g; 95% CI -1120 g to 2614 g; P = .431). RRSO women may have gained slightly more abdominal visceral adipose tissue (mean difference 99.0 g; 95% CI 8.8 g to 189.2 g; P = .032) but there were no other differences in body composition. There were also no differences in weight or body composition between HRT users and nonusers at 24 months. Conclusion 24 months after RRSO, there was no difference in body weight compared with women who retained their ovaries. RRSO women gained more abdominal visceral adipose tissue than comparators, but there were no other differences in body composition. Use of HRT following RRSO had no effect on these outcomes.
引用
收藏
页码:E397 / E405
页数:9
相关论文
共 50 条
  • [1] Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy
    Stuursma, A.
    van Driel, C. M. G.
    Wessels, N. J.
    de Bock, G. H.
    Mourits, M. J. E.
    MATURITAS, 2018, 111 : 69 - 76
  • [2] What happens after menopause(WHAM): A prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy
    Hickey, Martha
    Moss, Katrina M.
    Brand, Alison
    Wrede, C. David
    Domchek, Susan M.
    Meiser, Bettina
    Mishra, Gita D.
    Joffe, Hadine
    GYNECOLOGIC ONCOLOGY, 2021, 161 (02) : 527 - 534
  • [3] What happens after menopause? (WHAM): A prospective controlled study of cognition 24 months after premenopausal risk-reducing salpingo-oophorectomy
    Maki, Pauline M.
    Rubin, Leah H.
    Krejany, Efrosinia O.
    Brand, Alison
    Hicke, Martha
    GYNECOLOGIC ONCOLOGY, 2025, 193 : 141 - 147
  • [4] What happens after menopause? (WHAM): A prospective controlled study of sleep quality up to 12 months after premenopausal risk-reducing salpingo-oophorectomy
    Hickey, Martha
    Moss, Katrina M.
    Krejany, Efrosinia O.
    Wrede, C. David
    Domchek, Susan M.
    Kirk, Judy
    Brand, Alison
    Trainer, Alison
    Mishra, Gita D.
    Baker, Fiona C.
    GYNECOLOGIC ONCOLOGY, 2021, 162 (02) : 447 - 453
  • [5] Loss of bone density and bone strength following premenopausal risk-reducing bilateral salpingo-oophorectomy: a prospective controlled study (WHAM Study)
    Jiang, H.
    Robinson, D. L.
    Lee, P. V. S.
    Krejany, E. O.
    Yates, C. J.
    Hickey, M.
    Wark, J. D.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (01) : 101 - 112
  • [6] What Happens After Menopause? (WHAM): A prospective controlled study of cardiovascular and metabolic risk 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy
    Hickey, Martha
    Moss, Katrina M.
    Mishra, Gita D.
    Krejany, Efrosinia O.
    Domchek, Susan M.
    Wark, John D.
    Trainer, Alison
    Wild, Robert A.
    GYNECOLOGIC ONCOLOGY, 2021, 162 (01) : 88 - 96
  • [7] Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy
    Tucker, Paige E.
    Bulsara, Max K.
    Salfinger, Stuart G.
    Tan, Jason Jit-Sun
    Green, Helena
    Cohen, Paul A.
    GYNECOLOGIC ONCOLOGY, 2016, 140 (01) : 95 - 100
  • [8] Sexual function following risk-reducing salpingo-oophorectomy: a prospective cohort study
    von Kartaschew, asa Ehlin
    Hirschberg, Angelica Linden
    Gemzell-Danielsson, K.
    Radestad, Angelique Floter
    SEXUAL MEDICINE, 2024, 12 (05)
  • [9] Risk factors for sexual dysfunction in BRCA mutation carriers after risk-reducing salpingo-oophorectomy
    Chan, Jessica L.
    Senapati, Suneeta
    Johnson, Lauren N. C.
    DiGiovanni, Laura
    Voong, Chan
    Butts, Samantha F.
    Domchek, Susan M.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (02): : 132 - 139
  • [10] Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy
    Johansen, Nora
    Liavaag, Astrid H.
    Iversen, Ole-Erik
    Dorum, Anne
    Braaten, Tonje
    Michelsen, Trond M.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2017, 96 (05) : 547 - 555